Amalgamated Bank’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Sell
682
-26
-4% -$8.23K ﹤0.01% 1568
2026
Q1
$228K Hold
708
﹤0.01% 1533
2025
Q4
$209K Buy
708
+109
+18% +$20.3K ﹤0.01% 1559
2025
Q3
$32K Hold
599
﹤0.01% 1974
2025
Q2
$25K Hold
599
﹤0.01% 2034
2025
Q1
$23K Buy
599
+2
+0.3% +$125 ﹤0.01% 2014
2024
Q4
$46K Hold
597
﹤0.01% 1856
2024
Q3
$34K Hold
597
﹤0.01% 1965
2024
Q2
$25K Buy
+597
New +$28.2K ﹤0.01% 2049
2023
Q2
Sell
-302
Closed -$4K 3102
2023
Q1
$4K Sell
302
-11
-4% -$464 ﹤0.01% 2912
2022
Q4
$11K Hold
313
﹤0.01% 2869
2022
Q3
$11K Buy
313
+1
+0.3% +$50 ﹤0.01% 2930
2022
Q2
$11K Buy
312
+36
+13% +$3.84K ﹤0.01% 2980
2022
Q1
$42K Buy
+276
New +$56.7K ﹤0.01% 2559

Other funds holding PRAX

Amalgamated Bank's PRAX Position: Q2 2026 in Review

Amalgamated Bank reduced its Praxis Precision Medicines (PRAX) stake by 3.7% in Q2 2026, selling an estimated $8.23K and leaving 682 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Amalgamated Bank first reported a position in PRAX in Q1 2022 and has held it in 14 quarters since. 95 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Amalgamated Bank held 682 shares of Praxis Precision Medicines worth $228K as of Q2 2026.
  • Amalgamated Bank sold 26 Praxis Precision Medicines shares in Q2 2026, an estimated $8.23K.
  • Praxis Precision Medicines made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1568 holding.
  • Amalgamated Bank first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 14 quarters since.
  • 95 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.